News

According to the FDA, tianeptine has a high potential for abuse with serious harmful effects by itself or with other drugs, ...
Novo Nordisk reports phase 3 data showing weekly Sogroya matched or outperformed daily hormone therapy in multiple pediatric growth disorders.
An iconic British drama has become an unlikely hit in Japan despite a string of mixed reviews in the UK. The six-part crime ...
Moving on, Mitolyn enhances its customer experience with its money-back guarantee. According to this policy, all Mitolyn ...
Biodexa Receives Orphan Drug Designation in Europe for eRapa in FAP New designation follows the U.S. Food and Drug Administration (FDA) Orphan Drug Designation for eRapa in FAP granted ...